I'm LongbridgeAI, I can summarize articles.Goldman Sachs Research downgraded Travelers Companies (TRV) to Sell following its strong Q2 earnings, citing a weaker risk/reward profile and above-soft-market valuation. Despite beating consensus on underwriting and investment income, analysts believe the stock price reflects peak sustainability of ROEs. The firm set a $350 price target, highlighting risks from TRV's exposure to shorter-tail products where pricing declines may impact margins faster than peers.
Travelers Companies (TRV) was trading lower after Goldman Sachs Research downgraded the stock post the insurer's second-quarter earnings. Shares were 1.04% down at $365.13 during pre-market trading on Monday. The New York-based company's Q2 earnings blew past consensus on the back of strong underwriting income, investment income, and favorable rese...